NewsSource: EClinCloud

Hi Friend, There's a Launch Event We'd Like to Share With You

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration


Dear Partners:


Thank you very much for your continued support of EClinCloud. We cordially invite you to attend the "Digital Breakthrough: Rising Together with EClinCloud" integrated clinical trial cloud platform launch event, to be held on July 17 at 16:30 at Shangri-La Qiantan, Shanghai. We have prepared specialized digital clinical trial solutions and a dinner for you, and have also invited industry leaders from across different fields to join you in exploring "The Path of Digital Transformation from Different Perspectives."

For registration details, please see the poster at the end of this article (this event is by invitation only with limited seating—register soon!).




Digital Breakthrough: Rising Together with EClinCloud


The pandemic continues to disrupt our work and daily lives, leaving too many new drug R&D programs stalled: patients are unable to attend site visits, data cannot be entered in a timely manner, and project team members cannot collaborate. Everything is posing challenges to our clinical research! When COVID-19 outbreaks occur and cities face lockdowns, a range of issues emerge, making everything even more difficult and creating an urgent need for a breakthrough.To ensure trial quality while improving trial efficiency, digitalization is one of the most effective approaches.


So, here we are!


To better address the challenges of digital transformation in clinical trials, EClinCloud will host a distinctive product launch event to officially introduce its integrated cloud platform with interconnected systems, which addresses many pain points in clinical trials through digital solutions.


We have invited prominent industry leaders from capital markets, hospitals, CROs, and research institutions to interpret the application and progress of digitalization in pharmaceutical R&D from multiple perspectives and explore its future direction with a globally leading international outlook.



Event Agenda

16:30-17:00

On-site Check-in

17:00-17:50

Keynote Speech: "Digital Breakthrough: Rising Together with EClinCloud"

· Dr. Qin Long, CEO of EClinCloud

17:50-18:20

Panel Discussion: "The Path of Digital Transformation from Different Perspectives"


18:20-18:30

EClinCloud Integrated Cloud Platform Launch Ceremony


18:30-20:00

Dinner

Article illustration


In-Person Attendance Registration:

Time: Sunday, July 17, 16:30–20:00

Venue: Shangri-La Qiantan, Shanghai, Floor 3, Qiantan Ballroom 2

Article illustration



Online Attendance Registration:

Livestream Time: Sunday, July 17, 17:00–18:30

Article illustration






About EClinCloud



EClinCloud is a healthcare and life sciences technology company rooted in China and serving the world. Guided by its mission of "bringing effective treatments to patients through technological innovation" and driven by science and medicine, it combines digital technology with life sciences data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




Article illustration



Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.